Home Alert: FTC Challenges 'No-AG' Agreement as Illegal Reverse Payment
 

Keywords :   


Alert: FTC Challenges 'No-AG' Agreement as Illegal Reverse Payment

2016-04-07 21:28:12| Biotech - Topix.net

On March 30 the US Federal Trade Commission filed suit in federal court alleging that settlements of patent litigation in the pharmaceutical industry in which a pioneer firm agrees not to market an "authorized generic" violate antitrust law. The FTC is seeking disgorgement of what it alleges are "ill-gotten gains" from Endo Pharmaceuticals, Inc. and a number of generic firms in the agency's second suit challenging patent litigation settlements since the Supreme Court's decision in FTC v.

Tags: agreement payment alert challenges

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11Idées de CADRES No.83
23.11 12BOX PREMIUMpack 25th
23.11V2box
23.11
23.11 &
23.11DVD('97/)E11387
23.117
23.11
More »